M. Gunkel

Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols

M. Schrappe, G. Henze, H. Müller, 2000, British journal of haematology.

PEG-asparaginase (Oncaspar) 2500 U/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols

M. Schrappe, G. Henze, H. Müller, 2002, Cancer Chemotherapy and Pharmacology.

Positive Selection of Hematopoietic Progenitor Cells for Autologous and Allogeneic Transplantation in Pediatric Patients with Solid Tumors and Leukemia

E. Seifried, J. Vogel, R. Kotchetkov, 2000 .

Drug monitoring of low‐dose PEG‐asparaginase (Oncaspartm) in children with relapsed acute lymphoblastic leukaemia

G. Henze, G. Würthwein, J. Boos, 2001, British journal of haematology.

High-Content Analysis of MicroRNAs Facilitates the Development of Combinatorial Therapies for Vascular Diseases

H. Erfle, N. Gretz, C. Sticht, 2021 .